New Urine Test Reduces Unnecessary Biopsies in Prostate Cancer Detection
Author: Raushanah Najeeullah, ND
A new urine test, MyProstateScore 2.0 (MPS2), offers better accuracy for detecting high-grade prostate cancer compared to current methods. In a recent study involving over 1,500 men, MPS2 reduced unnecessary biopsies by up to 51% while still identifying significant cancers with high sensitivity. This test improves on the PSA test by specifically targeting 17 genes linked to high grade aggressive prostate cancer, making it a promising non-invasive tool for reducing the risks and discomfort associated with prostate cancer screening.
Source: Tosoian JJ, Zhang Y, Xiao L, et al. Development and Validation of an 18-Gene Urine Test for High-Grade Prostate Cancer. JAMA Oncology. 2024-06-01 2024;10(6):726. doi:10.1001/jamaoncol.2024.0455
Empower Your Health Journey
Ready to take the first step toward personalized, whole-person care?
Schedule your complimentary discovery call by filling out the form below. We'll learn about your health goals, answer your questions, and help determine the best path forward for your care.